手術衣市場:現狀分析與預測(2022-2030年)
市場調查報告書
商品編碼
1290906

手術衣市場:現狀分析與預測(2022-2030年)

Surgical Gowns Market: Current Analysis and Forecast (2022-2030)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

由於醫療旅遊業的全球擴張,手術服市場預計將穩定增長10%左右。例如,根據醫療旅遊協會的數據,全球每年有近 1400 萬人前往不同國家尋求醫療服務。這項活動價值在 50,000 美元到 70,000 美元之間。由於這些事實以及外科手術國際標準的不斷遵守,預計手術服市場在預測期內也將增長。

為了更好地了解手術衣行業的市場採用情況,我們根據其在北美(美國、加拿大、北美其他地區)、歐洲(德國、英國、法國、西班牙)等國家/地區的全球分佈對市場進行了分析。 、意大利、歐洲其他地區)、亞太地區(中國、日本、印度、亞太地區其他地區)、世界其他地區。由於慢性病患病率不斷上升,預計北美在預測期內將以復合年增長率大幅增長疾病如癌症和糖尿病,加上人口老齡化,正在推動對手術服的需求。包括微創手術在內的手術的增加也促進了市場的增長。手術服的採用,特別是可重複使用的選擇,具有成本效益和環境可持續。

目錄

第1章 市場簡介

  • 市場定義
  • 主要目的
  • 相關利益者
  • 限制事項

第2章 調查手法或前提

  • 調查流程
  • 調查手法
  • 受訪者簡介

第3章 市場摘要

第4章 摘要整理

第5章 COVID-19對手術衣市場帶來的影響

第6章 手術衣的市場收益,2020-2030年

第7章 市場洞察:各產品

  • 拋棄式
  • 可重複使用

第8章 市場洞察:各流通管道

  • 線上銷售
  • 零售藥局
  • 直銷

第9章 市場洞察:各最終用途

  • 醫院
  • 門診病人手術中心
  • 診斷中心
  • 診所
  • 其他

第10章 市場洞察:各最終用途

  • 製藥公司及生物醫藥品公司
  • 臨床調查機構
  • 醫療保健提供者

第11章 市場洞察:各地區

  • 北美
    • 美國
    • 加拿大
    • 其他北美地區
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 全球其他地區

第12章 手術衣市場動態

  • 推動市場要素
  • 市場課題
  • 影響分析

第13章 手術衣市場機會

第14章 手術衣市場趨勢

第15章 需求面和供給面的分析

  • 需求面分析
  • 供給面分析

第16章 價值鏈分析

第17章 價格分析

第18章 策略性洞察能力

第19章 競爭模式

  • 競爭情形
    • 波特的五力分析

第20章 企業簡介

  • Cardinal Health
  • 3M
  • Molnlycke Health Care AB
  • Owens & Mino
  • Thermo Fisher Scientific Inc.
  • STERIS
  • PAUL HARTMANN AG
  • Johnson & Johnson Private Limited
  • Medica Europe B.V.
  • Medline Industries, Inc.

第21章 免責聲明

簡介目錄
Product Code: UMHE2118021

Patients receiving care or being inspected at a clinic or hospital, as well as doctors performing procedures, wear surgical gowns, which are short, collarless gowns tied at the back. The surgical gown market is growing on account of the growing number of surgeries and increasing incidences of healthcare-associated infections (HAIs) which are directly associated with the lack of precaution and sanitation. For instance, every year 1.7 million people get an infection during a hospital stay. Also, almost 98,987 people in the U.S. die annually from HAIs. Furthermore, some other factors also boost the growth of the market such as new technological advancement in the healthcare sector and an increase in healthcare expenditure.

The surgical gowns market is expected to grow at a steady rate of around 10% owing to the growing medical tourism industry across the globe is also driving the market globally. For instance, according to the Medical Tourism Association, nearly 14 million people around the globe travel to different countries in search of medical care per year. It is an activity worth between 50 and 70 thousand million dollars. Owing to these facts and growing compliance towards an international standard for surgical procedures, the surgical gowns market is also expected to grow during the forecast period.

Based on product, the market is segmented into disposable and reusable. The disposable category is to witness higher adoption during the forecast period as they are cost-effective and are recommended over reusable gowns in terms of safety and quality. Disposable gowns are made from hypoallergenic and dermatological-certified materials and serve to limit the danger of infection and cross-contamination among patients. Also, the growth of the market is accelerated by some factors such as the increasing number of surgical procedures due to sports injuries, accidents, and heart surgeries owing to a high prevalence of chronic diseases where surgery is being suggested. For instance, according to the OECD stats, in the United Kingdom, the total number of surgical procedures performed was 4,82,938 in 2017 and it increased to 5,40,947 in 2019.

On the basis of distribution channel, the market is categorized into online sales, retail pharmacies, and direct sales. Among these, retail pharmacies held a significant share of the market in 2021. This is mainly due to being easily accessible to patients and healthcare providers, convenient options for patients, more affordable for patients, compliance with regulations, and retail pharmacies can create awareness among their customers about the importance of surgical gowns which will boost the growth of the market.

Based on end-user, the surgical gowns market has been classified into hospitals, ambulatory surgical centers, diagnostic centers, clinics, and others. The military and defense category is to witness higher adoption of surgical gowns during the forecast period. This is mainly due to the majority of surgical gowns are utilized in hospitals, the rising prevalence of chronic diseases, improving healthcare infrastructure, and the expanding number of hospitals. The spreading of viral infections and the constant rise in surgical procedures chosen by patients worldwide to treat chronic diseases.

For a better understanding of the market adoption of the surgical gowns industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period owing to the increasing prevalence of chronic diseases such as cancer and diabetes, coupled with an aging population, is driving the demand for surgical gowns. The rise in surgeries, including minimally invasive procedures, is also contributing to market growth. In addition, the focus on infection control measures in healthcare facilities is driving the adoption of surgical gowns, particularly reusable options, which are cost-effective and environmentally sustainable. The implementation of stringent regulatory guidelines is also expected to contribute to market growth in the region.

Some of the major players operating in the market include: Cardinal Health; 3M; Molnlycke Health Care AB; Owens & Mino; Thermo Fisher Scientific Inc.; STERIS; PAUL HARTMANN AG; Johnson & Johnson Private Limited; Medica Europe B.V.; Medline Industries, Inc.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Surgical Gowns Market
  • 2.2. Research Methodology of the Surgical Gowns Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE SURGICAL GOWNS MARKET

6 SURGICAL GOWNS MARKET REVENUE, 2020-2030F

7 MARKET INSIGHTS BY PRODUCT

  • 7.1. Disposable
  • 7.2. Reusable

8 MARKET INSIGHTS BY DISTRIBUTION CHANNEL

  • 8.1. Online Sales
  • 8.2. Retail Pharmacies
  • 8.3. Direct Sales

9 MARKET INSIGHTS BY END-USER

  • 9.1. Hospitals
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Diagnostic Centers
  • 9.4. Clinics
  • 9.5. Others

10 MARKET INSIGHTS BY END-USERS

  • 10.1. Pharmaceutical & Biopharmaceutical Companies
  • 10.2. Clinical Research Organization
  • 10.3. Healthcare Providers

11 MARKET INSIGHTS BY REGION

  • 11.1. North America
    • 11.1.1. U.S.
    • 11.1.2. Canada
    • 11.1.3. Rest of North America
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. U.K.
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Rest of Asia-Pacific
  • 11.4. Rest of World

12 SURGICAL GOWNS MARKET DYNAMICS

  • 12.1. Market Drivers
  • 12.2. Market Challenges
  • 12.3. Impact Analysis

13 SURGICAL GOWNS MARKET OPPORTUNITIES

14 SURGICAL GOWNS MARKET TRENDS

15 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 15.1. Demand Side Analysis
  • 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 PRICING ANALYSIS

18 STRATEGIC INSIGHTS

19 COMPETITIVE SCENARIO

  • 19.1. Competitive Landscape
    • 19.1.1. Porters Fiver Forces Analysis

20 COMPANY PROFILED

  • 20.1. Cardinal Health
  • 20.2. 3M
  • 20.3. Molnlycke Health Care AB
  • 20.4. Owens & Mino
  • 20.5. Thermo Fisher Scientific Inc.
  • 20.6. STERIS
  • 20.7. PAUL HARTMANN AG
  • 20.8. Johnson & Johnson Private Limited
  • 20.9. Medica Europe B.V.
  • 20.10. Medline Industries, Inc.

21 DISCLAIMER